Compass - Charting the Way Ahead

In late 2019, the world first heard about COVID-19. Since then, the virus has swept the globe. In a bid to understand the end-to-end supply chain impacts of the pandemic for reproductive health products in low- and middle-income countries, an in-depth assessment was commissioned: Building resilient sexual and reproductive health supply chains during COVID-19 and beyond: a community roadmap for action and technical findingsThe Roadmap contains a series of broad, far-reaching recommendations in the areas of RH product markets, financing, supply chain strategies, policies, stewardship, and data.

Now, we offer you an initiative to help put the Roadmap into action. Compass — Charting the Way Ahead builds on the Roadmap’s analysis and findings, helping to point the way as our community navigates through these unprecedented times, and prepares for a post-pandemic reality.

The latest report

Manufacturing Landscape Assessment for Maternal Health Supplies in SubSaharan Africa

In sub-Saharan Africa (SSA), disruptions in health supply chains, limited regional pharmaceutical production, and excessive reliance on foreign imports combine to impede availability of essential maternal health (MH) products. A new report assesses the demand for—and manufacturing capacity of—five essential MH commodities across eight SSA countries. Produced by US Pharmacopeia (USP) and the Reproductive Health Supplies Coalition (RHSC), the report highlights a lack of diversified regional suppliers, overreliance on foreign imports, and varying capacity and distribution of regional manufacturers as challenges that affect availability, access, and affordability of essential MH medicines.

Download the report

Download the summary factsheet

Priority Areas

From globalization to greater regionalization of supply chains

Managing the competition for scarce resources

Learning from adaptations 

You are currently offline. Some pages or content may fail to load.